Drug Approval | December 17, 2023
Zydus receives final USFDA approval for Cyclophosphamide Capsules USP, 25 mg and 50 mg
Cyclophosphamide is a chemotherapy medication that slows the growth of cancer cell
Cyclophosphamide is a chemotherapy medication that slows the growth of cancer cell
The exclusive agreement also includes development, regulatory, and commercialization milestone payments based on the successful outcome
New facility is part of Aptar Pharma’s global expansion program
Express Scripts to add Zepbound to National Preferred Formulary
The company is assessing the situation and simultaneously undertaking all the requisite action
This product will be manufactured by Indoco Remedies at their manufacturing facility located at Goa
Dr. Reddy's will make a US$ 7.5 million upfront payment to Coya
Methylene blue is a cationic thiazine dye that necessitates specialised capabilities and expertise to develop and manufacture the product
Ivabradine Tablets, 5 mg and 7.5 mg had annual sales of USD 136.5 mn in the United States
The CAPSUL solution enables optimal process performance for production of premier quality PCL grades at competitive rates
Subscribe To Our Newsletter & Stay Updated
